World Journal of Surgery

, Volume 34, Issue 9, pp 2128–2132 | Cite as

Pancreaticoduodenectomy After Liver Transplantation in Patients with Primary Sclerosing Cholangitis Complicated by Distal Pancreatobiliary Malignancy

  • Robert P. Sutcliffe
  • Wayne Lam
  • Adrian O’Sullivan
  • Andreas PrachaliasEmail author
  • Mohamed Rela
  • Nigel Heaton



The aim of this study was to examine the use of pancreaticoduodenectomy for malignancy in patients who have undergone liver transplantation for primary sclerosing cholangitis (PSC).


Patients who underwent simultaneous or sequential pancreaticoduodenectomy after liver transplantation were identified from a prospective transplant database. Preoperative, perioperative, and follow-up data were collected by review of patients’ medical records.


Four patients with PSC underwent simultaneous (1) or sequential (3) pancreaticoduodenectomy for the treatment of distal cholangiocarcinoma (2) or pancreatic adenocarcinoma (2). Postoperative complications occurred in two patients (1 pneumonia and 1 wound infection). Tumour resection margins were negative in all cases. Two patients with node-negative tumours were disease-free after 5 years and 23 months, and two patients with node-positive tumours died of recurrence after 5 and 10 months.


Pancreaticoduodenectomy after liver transplantation can be performed with low morbidity in specialist centres with expertise in both liver transplantation and major pancreatic surgery. Patients with resectable disease should be treated aggressively, although long-term results will be dictated by the histological stage of the tumour, particularly lymph node status.


Liver Transplantation Cholangiocarcinoma Pancreatic Adenocarcinoma Primary Sclerosing Cholangitis Locoregional Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bergquist A, Ekbom A, Olsson R et al (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36(3):321–327CrossRefPubMedGoogle Scholar
  2. 2.
    Ahrendt SA, Pitt HA, Nakeeb A et al (1999) Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Surg 3(4):357–672CrossRefPubMedGoogle Scholar
  3. 3.
    Goss JA, Shackleton CR, Farmer DG et al (1997) Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 225(5):472–481CrossRefPubMedGoogle Scholar
  4. 4.
    Rea DJ, Heimbach JK, Rosen CB et al (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242(3):451–458PubMedGoogle Scholar
  5. 5.
    Cherqui D, Alon R, Fagniez PL et al (1995) Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg 82(3):397–398CrossRefPubMedGoogle Scholar
  6. 6.
    Neuhaus P (1996) Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg 83(3):422CrossRefPubMedGoogle Scholar
  7. 7.
    Wu Y, Johlin FC, Mitros FA et al (2008) Long-term, tumor-free survival after radiotherapy combining hepatectomy-whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl 14(3):279–286CrossRefPubMedGoogle Scholar
  8. 8.
    Soejima Y, Ueda S, Maehara Y et al (2008) Sequential pancreatoduodenectomy after living donor liver transplantation for cholangiocarcinoma. Am J Transplant 8(10):2158–2162CrossRefPubMedGoogle Scholar
  9. 9.
    Stauffer JA, Steers JL, Bonatti H et al (2009) Liver transplantation and pancreatic resection: a single center experience and a review of the literature. Liver Transpl 15(12):1728–1737CrossRefPubMedGoogle Scholar
  10. 10.
    Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91(11):1410–1427CrossRefPubMedGoogle Scholar
  11. 11.
    Talwalkar JA, Lindor KD (2005) Primary sclerosing cholangitis. Inflamm Bowel Dis 11(1):62–72CrossRefPubMedGoogle Scholar
  12. 12.
    Claessen MM, Vleggaar FP, Tytgat KM et al (2009) High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 50(1):158–164CrossRefPubMedGoogle Scholar
  13. 13.
    Seehofer D, Thelen A, Neumann UP et al (2009) Extended bile duct resection and liver transplantation in patients with hilar cholangiocarcinoma: long-term results. Liver Transpl 15(11):1499–1507CrossRefPubMedGoogle Scholar
  14. 14.
    Castroagudin JF, Molina E, Tome S et al (2009) Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence. Transplant Proc 41(3):1003–1004CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Robert P. Sutcliffe
    • 1
  • Wayne Lam
    • 1
  • Adrian O’Sullivan
    • 1
  • Andreas Prachalias
    • 1
    Email author
  • Mohamed Rela
    • 1
  • Nigel Heaton
    • 1
  1. 1.Institute of Liver StudiesKing’s College HospitalLondonUK

Personalised recommendations